Overall, these data indicate that: CCL2 triggers interactions among CCR2, MET and SRC in breast cancer cells, and CCL2 regulates MET phosphorylation through CCR2- and SRC-dependent mechanisms. This evidence concerns the gene CCL2 and breast carcinoma.